7-82005506-GAAAAA-GA
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_000722.4(CACNA2D1):c.1516-13_1516-10delTTTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000175 in 1,202,536 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.000011 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000018 ( 0 hom. )
Consequence
CACNA2D1
NM_000722.4 intron
NM_000722.4 intron
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 2.66
Publications
0 publications found
Genes affected
CACNA2D1 (HGNC:1399): (calcium voltage-gated channel auxiliary subunit alpha2delta 1) The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]
CACNA2D1 Gene-Disease associations (from GenCC):
- short QT syndromeInheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: ClinGen, Orphanet
- Brugada syndromeInheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- developmental and epileptic encephalopathy 110Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNA2D1 | NM_000722.4 | c.1516-13_1516-10delTTTT | intron_variant | Intron 17 of 38 | ENST00000356860.8 | NP_000713.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA2D1 | ENST00000356860.8 | c.1516-13_1516-10delTTTT | intron_variant | Intron 17 of 38 | 1 | NM_000722.4 | ENSP00000349320.3 |
Frequencies
GnomAD3 genomes AF: 0.0000109 AC: 1AN: 91634Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
91634
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000180 AC: 20AN: 1110902Hom.: 0 AF XY: 0.0000197 AC XY: 11AN XY: 558240 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
20
AN:
1110902
Hom.:
AF XY:
AC XY:
11
AN XY:
558240
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
25500
American (AMR)
AF:
AC:
1
AN:
31716
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
22032
East Asian (EAS)
AF:
AC:
0
AN:
34320
South Asian (SAS)
AF:
AC:
1
AN:
69362
European-Finnish (FIN)
AF:
AC:
0
AN:
47192
Middle Eastern (MID)
AF:
AC:
0
AN:
4084
European-Non Finnish (NFE)
AF:
AC:
18
AN:
829264
Other (OTH)
AF:
AC:
0
AN:
47432
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.00000000575), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.305
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000109 AC: 1AN: 91634Hom.: 0 Cov.: 31 AF XY: 0.0000226 AC XY: 1AN XY: 44178 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
91634
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
44178
show subpopulations
African (AFR)
AF:
AC:
0
AN:
26072
American (AMR)
AF:
AC:
0
AN:
9010
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2038
East Asian (EAS)
AF:
AC:
0
AN:
2972
South Asian (SAS)
AF:
AC:
1
AN:
2758
European-Finnish (FIN)
AF:
AC:
0
AN:
5886
Middle Eastern (MID)
AF:
AC:
0
AN:
162
European-Non Finnish (NFE)
AF:
AC:
0
AN:
41016
Other (OTH)
AF:
AC:
0
AN:
1214
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.